Catalog Number 320883 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Bruise/Contusion (1754); Blood Loss (2597)
|
Event Date 12/11/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
Date of event: unknown.Medical device expiration date: n/a.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Event Description
|
"t" was reported that the consumer experienced bruising and bleeding after injecting when using bd¿ nano ultra-fine pen needles.The consumer addressed this issue with her doctor during her next visit.
|
|
Event Description
|
It was reported that the consumer experienced bruising and bleeding after injecting when using bd¿ nano ultra-fine pen needles.The consumer addressed this issue with her doctor during her next visit.
|
|
Manufacturer Narrative
|
Investigation summary: customer returned ( 5 ) 4mm, 32g sealed bd pen needles.Customer reports bruising and bleeding after she injects.All 5 returned pen needles were tested for point geometry, outer diameter and lube coverage.The following was observed (specs: outer diameter for 32g: 0.0090¿- 0.0095¿): data: point (pe/npe) outer diameter (in) lube sample 1: good/good.0.0090; good.Sample 2: good/good.0.0090; good.Sample 3: good/good.0.0091; good.Sample 4: good/good.0.0091; good.Sample 5: good/good.0.0090; good.A lot history review was carried out and no related non conformances were raised in association with this packaged lot concluding all inspections were performed per the applicable operations and met qc specifications.Based on the samples / photo(s) received the investigation concluded: unconfirmed: bd was not able to duplicate or confirm the customer¿s indicated failure.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.Based on the above, no additional investigation and no capa is required at this time.
|
|
Event Description
|
It was reported that the consumer experienced bruising and bleeding after injecting when using bd¿ nano ultra-fine pen needles.The consumer addressed this issue with her doctor during her next visit.
|
|
Manufacturer Narrative
|
Correction: describe event or problem: it was reported that the consumer experienced bruising and bleeding after injecting when using bd¿ nano ultra-fine pen needles.The consumer addressed this issue with her doctor during her next visit.In section h.10 of the previously submitted mdr, sections d.1 was incorrectly referenced as the medical device expiration date and device manufacture date.This supplemental mdr is being submitted to correct those references to show the following: medical device expiration date.
|
|
Search Alerts/Recalls
|